Telix Pharmaceuticals (TLX) Liabilities and Shareholders Equity (2023 - 2025)
Telix Pharmaceuticals (TLX) posted Liabilities and Shareholders Equity of $1.2 billion for Q4 2025, up 17.38% on a QoQ basis from $991.7 million in Q4 2024, and up 17.38% year-over-year from $991.7 million in Q4 2024.
Telix Pharmaceuticals (TLX) has 3 years of Liabilities and Shareholders Equity data on file, last reported at $1.2 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 14.93 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.37 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.73 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 78.88 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 33.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.48 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 23.64 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.87 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.13 Bn |
| 10 | Telix Pharmaceuticals | 4.52 Bn | 4.38 Bn | - | 1.16 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.16 Bn |
| Dec 31, 2024 | 991.68 Mn |
| Dec 31, 2023 | 264.27 Mn |